Inhibitory effects of J78, a newly synthesized 1,4-naphthoquinone derivative, on experimental thrombosis and platelet aggregation

Pharmacology

Volumn 70, Issue 4, 2004, Pages 195-200

  Jin, Yong Ri ^a   Ryu, Chung Kyu ^b   Moon, Chang Kiu ^c   Cho, Mi Ra ^a   Yun, Yeo Pyo ^a  

^a Chungbuk National University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

1,4 Naphthoquinone; Antithrombotic agent; Coagulation; Platelet aggregation; Thrombosis

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2 CHLORO 3 (2' BROMO 4' FLUOROPHENYL)AMINO 8 HYDROXY 1,4 NAPHTHOQUINONE; ADRENALIN; COLLAGEN; J 78; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SYNTHESIS; LUNG EMBOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ANIMALS; COLLAGEN; EPINEPHRINE; FIBRINOLYTIC AGENTS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MICE; NAPHTHOQUINONES; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION; PULMONARY EMBOLISM; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTOR AGENTS;

EID: 1542343907     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075548     Document Type: Article

References (38)

1. Sherman DG, Hart RG: Thromboembolism and antithrombotic therapy in cerebrovascular disease. J Am Coll Cardiol 1986;8(suppl B):88-97.
2. Hjemdahl-Monsen CE, Lewis HD, Cairns J, Chesebro JH, Fuster V: Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death. J Am Coll Cardiol 1986;8(suppl B):67-75.
3. Grande P, Grauholt AM, Madsen JK: Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. Circulation 1990;81(suppl):I16-I19 , I22-I23.
4. Trip MD, Cats VM, van Capelle FJ, Vreeken J: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;322:1549-1554.
5. Genton E, Clagett GP, Salzman EW: Antithrombotic therapy in peripheral vascular disease. Chest 1986;89(suppl):75-81.
6. Hennekens CH, Buring JE, Sandercock P, Collins R, Peto R: Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 1989;80:749-756.
7. King SB 3rd: Optimizing antiplatelet therapy in coronary interventions. Clin Cardiol 2000;23(suppl 6):8-13.
8. Schror K: Antiplatelet drugs. A comparative review. Drugs 1995;50:7-28.
9. Bennett JS: Novel platelet inhibitors. Annu Rev Med 2001;52:161-184.
10. 3 inhibition of malignant murine cell growth and human tumor colony formation. Cancer Treat Rep 1985;69:527-532.
11. Rodriguez S, Wolfender JL, Hakizamungu E, Hostettmann K: An antifungal naphthoquinone, xanthones and secoiridoids from Swertia calycina. Planta Med 1995;61:362-364.
12. Ishikawa T, Kotake K, Ishii H: Synthesis of toddacoumaquinone, a coumarin-naphthoquinone dimer, and its antiviral activities. Chem Pharm Bull (Tokyo) 1995;43:1039-1041.
13. 2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets. Biochem Pharmacol 1997;54:259-268.
14. Ko FN, Sheu SJ, Liu YM, Huang TF, Teng CM: Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones. Thromb Res 1990;57:453-463.
15. Liao CH, Ko FN, Kuo SC, Teng CM: Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets. Jpn J Pharmacol 1998;76:141-148.
16. Shen AY, Huang MH, Teng CM, Wang JS: Inhibition of 2-P-mercaptophenyl-1, 4-naphthoquinone on human platelet function. Life Sci 1999;65:45-53.
17. Kang WS, Ryu CK, Chung KH, Ko MW, Joo JC, Yuk DY, Yoo HS, Yun YP: Antiplatelet and antithrombotic activities of NQ301, 2-chloro-3-(4-acetophenyl)- amino-1,4-naphthoquinone. Biol Pharm Bull 1999;22:1284-1287.
18. Yuk DY, Lee HY, Ryu CK, Hong JT, Kang WS, Yoo HS, Yun YP: Studies on the antithrombotic and antiplatelet activities of NQ304, a newly synthesized naphthoquinone derivative. Arzneimittelforschung 2000;50:254-259.
19. Yuk DY, Ryu CK, Hong JT, Chung KH, Kang WS, Kim Y, Yoo HS, Lee MK, Lee CK, Yun YP: Antithrombotic and antiplatelet activities of 2-chloro-3-[4- (ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative. Biochem Pharmacol 2000;60:1001-1008.
20. 2+ mobilization. Biol Pharm Bull 2001;24:618-622.
21. Zhang YH, Chung KH, Ryu CK, Lee YH, Kim TJ, Song YS, Hwang KA, Yun YP: Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an antithrombotic agent. Pharmacol Toxicol 2001;88:181-186.
22. Thomson SH: Studies in the juglone series 1. Some halogen derivatives and their reaction with aniline. J Org Chem 1948;13:377-383.
23. Kang WS, Chung KH, Chung JH, Lee JY, Park JB, Zhang YH, Yoo HS, Yun YP: Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovasc Pharmacol 2001;38:875-884.
24. Kang WS, Lim IH, Yuk DY, Chung KH, Park JB, Yoo HS, Yun YP: Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res 1999;96:229-237.
25. Silver MJ, Hoch W, Kocsis JJ, Ingerman CM, Smith JB: Arachidonic acid causes sudden death in rabbits. Science 1974;183:1085-1087.
26. Nishizawa E, Wynalda DJ, Suydam DE, Sawa TR, Schultz JR: Collagen-induced pulmonary thromboembolism in mice. Thromb Res 1972;1:233-242.
27. 2 during arachidonate infusion in rabbits. Thromb Res 1978;12:549-553.
28. Anon: Mechanisms of stimulus-response coupling in platelets. London, Sept 26-27 1984. Adv Exp Med Biol 1985;192:1-444.
29. 2 receptor interaction. J Pharmacol Exp Ther 1984;228:240-244.
30. Siess W, Siegel FL, Lapetina EG: Arachidonic acid stimulates the formation of 1,2-diacylglycerol and phosphatidic acid in human platelets. Degree of phospholipase C activation correlates with protein phosphorylation, platelet shape change, serotonin release and aggregation. J Biol Chem 1983;258:11236-11242.
31. Brass LF, Shaller CC, Belmonte EJ: Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin. J Clin Invest 1987;79:1269-1275.
32. Cowan DH, Robertson AL, Shook P, Giroski P: Platelet adherence to collagen: Role of plasma, ADP and divalent cations. Br J Haematol 1981;47:257-267.
33. Cowan DH: Platelet adherence to collagen: Role of prostaglandin- thromboxane synthesis. Br J Haematol 1981;49:425-434.
34. Sixma JJ, van Zanten GH, Huizinga EG, van der Plas RM, Verkley M, Wu YP, Gros P, de Groot PG: Platelet adhesion to collagen: an update. Thromb Haemost 1997;78:434-438.
35. Lapetina EG: The signal transduction induced by thrombin in human platelets. FEBS Lett 1990;268:400-404.
36. 2+ ionophores. Br J Haematol 2001;112:603-608.
37. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 1993;361:315-325.
38. 2+ entry by cAMP-dependent and cGMP-dependent protein kinases and phospholipase C in rat platelets. Eur J Biochem 1994;223:543-551.